Cumberland Pharmaceuticals (CPIX) Other financing activities (2010 - 2022)
Cumberland Pharmaceuticals (CPIX) posted Other financing activities of -$370464.0 for Q1 2022, up 41.44% sequentially from -$632646.0 in Q4 2021, and down 232.3% YoY from $280020.0 in Q1 2021.
Cumberland Pharmaceuticals (CPIX) Other financing activities (2010 - 2022) Analysis & Trends
Cumberland Pharmaceuticals has reported Other financing activities for 12 years, with the latest figure at -$370464.0 in Q1 2022.
- Quarterly Other financing activities fell 232.3% year-over-year to -$370464.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was -$650484.0 (down 147.35% YoY) and the FY2019 annual result came in at $52500.0, changed N/A from the prior year.
- Other financing activities climbed to -$370464.0 in Q1 2022 per CPIX's latest filing, from -$632646.0 in the prior quarter.
- Over five years, Other financing activities peaked at $543006.0 in Q1 2020 and troughed at -$806390.0 in Q4 2020.
- A 4-year average of -$24458.8 and a median of $102565.0 in 2020 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2021 and 2022: Other financing activities jumped 181.39% in 2021, then tumbled 232.3% in 2022.
- Over 4 years, Other financing activities stood at -$629077.0 in 2019, then retreated by 28.19% to -$806390.0 in 2020, then increased by 21.55% to -$632646.0 in 2021, then surged by 41.44% to -$370464.0 in 2022.
- According to Business Quant data, Other financing activities over the past three periods registered -$370464.0, -$632646.0, and $452536.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -370,464.00 |
| Mar 31, 2022 | -370,464.00 |
| Dec 31, 2021 | -632,646.00 |
| Dec 31, 2021 | -632,646.00 |
| Sep 30, 2021 | 452,536.00 |
| Sep 30, 2021 | 452,536.00 |
| Jun 30, 2021 | -99,910.00 |
| Jun 30, 2021 | -99,910.00 |
| Mar 31, 2021 | 280,020.00 |
| Mar 31, 2021 | 280,020.00 |
| Dec 31, 2020 | -806,390.00 |
| Dec 31, 2020 | -806,390.00 |
| Sep 30, 2020 | 160,819.00 |
| Sep 30, 2020 | 160,819.00 |
| Jun 30, 2020 | 102,565.00 |
| Jun 30, 2020 | 102,565.00 |
| Mar 31, 2020 | 543,006.00 |
| Mar 31, 2020 | 543,006.00 |
| Dec 31, 2019 | -629,077.00 |
| Dec 31, 2019 | -629,077.00 |